Alhajress, R., AlQahtani, B., AlQahtani, D., Alenazi, J. (2018). Massive Transfusion Complications Following Cutaneous Hemangioma. The Egyptian Journal of Hospital Medicine, 73(10), 7726-7729. doi: 10.21608/ejhm.2018.20111
Rafeef Alhajress; Bader Muaykil AlQahtani; Dhabiah AlQahtani; Jaber Alenazi. "Massive Transfusion Complications Following Cutaneous Hemangioma". The Egyptian Journal of Hospital Medicine, 73, 10, 2018, 7726-7729. doi: 10.21608/ejhm.2018.20111
Alhajress, R., AlQahtani, B., AlQahtani, D., Alenazi, J. (2018). 'Massive Transfusion Complications Following Cutaneous Hemangioma', The Egyptian Journal of Hospital Medicine, 73(10), pp. 7726-7729. doi: 10.21608/ejhm.2018.20111
Alhajress, R., AlQahtani, B., AlQahtani, D., Alenazi, J. Massive Transfusion Complications Following Cutaneous Hemangioma. The Egyptian Journal of Hospital Medicine, 2018; 73(10): 7726-7729. doi: 10.21608/ejhm.2018.20111
Massive Transfusion Complications Following Cutaneous Hemangioma
1King Saud Bin Abdulaziz University for Health Sciences, Riyadh
2King Abdullah Specialized Children’s Hospital, National Guard Health Affairs, Riyadh
3King Saud Bin Abdulaziz University For Health Sciences, Riyadh
4King Abdullah Bin Abdulaziz University Hospital
Abstract
Aim of the work: Describe the clinical events of a patient experiencing MT complications following cutaneous hemangioma resection since there is still no clear evidence on how to approach pediatric transfusion as the existing literature is lacking. Methodology: Patient information was obtained from medical records after taking permission. Personal information that has been collected shall not be disclosed prior to consent. Patient’s clinical course was mentioned in a chronological order with literature review to show significance of such cases in medical practice. Results: A seven-month-old male who was found to have cutaneous hemangioma that required resection. Along to the clinical course, experienced several complications secondary to a massive transfusion. Conclusion: Massive transfusion management in patients with non-traumatic-related hemorrhage, or surgery-related hemorrhage, is crucial for survival and better outcomes.